We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

BIO-RAD LABORATORIES

Provides full range of instrumentation, reagent kits, software and quality control systems to clinical laboratories. ... read more Featured Products: More products

Download Mobile App





Bio-Rad Offers Live Demonstrations of Innovative Lab Solutions

By LabMedica International staff writers
Posted on 29 Jul 2025

Bio-Rad Laboratories (Hercules, CA, USA) is offering live demonstrations of its innovative solutions and an engaging industry workshop at ADLM 2025. More...

Bio-Rad is spotlighting innovative technologies supporting laboratory workflows. Lab professionals can take part in live demonstrations of the company’s advanced blood-typing systems, high-throughput multiplex assays, and streamlined quality control data management tools. Visitors can get personalized walkthroughs of Bio-Rad’s QC solutions, transfusion medicine automation, autoimmune and infectious disease multiplexing, and HPLC testing platforms. Among its QC solutions highlighted at the show is Unity QC Data Management Solution, the industry’s leading software solution specifically designed to optimize QC laboratory practices and streamline workflows. The company’s robust laboratory QC software tools help improve analytical performance and achieve a higher level of confidence in patient test results.

At ADLM 2025, Bio-Rad is highlighting the IH 500 NEXT System, a medium-throughput blood typing instrument designed to help labs achieve immunohematology excellence. It combines functionality and design to meet the changing needs of the modern immunohematology laboratory by reducing hands-on time and providing faster time to results. Bio-Rad is also showcasing the BioPlex 2200 System, a fully automated, random-access multiplex system that allows clinical laboratories to maximize efficiency for autoimmune, infectious disease, and specialty testing. Visitors to the company’s booth can also experience the D-100 Hemoglobin Testing System, which simplifies high-throughput A1c testing without sacrificing the high-quality results that are critical to patient care.

Bio-Rad’s industry workshop titled “From Waste to Wow: Optimizing Your Quality Control Workflow” is designed to provide attendees with strategies to streamline QC management across multihospital systems for systemwide efficiency, reduce waste streams in clinical chemistry, and recognize patient-based real-time QC to improve lab QC processes. The event features presentations by Joshua Hayden, PhD, section director, clinical biochemistry, Cleveland Clinic; Joe Wiencek, PhD, associate professor of pathology, microbiology, and immunology at Vanderbilt School of Medicine; and John Yundt-Pacheco, MSCS, senior principal scientist at Bio-Rad. Lab professionals can also earn P.A.C.E. credits at the workshop.

Related Links:
Bio-Rad Laboratories


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
Japanese Encephalitis Test
Japanese Encephalitis Virus Real Time PCR Kit
Platinum Member
Integrated Biochemical & Immunological System
Biolumi CX Solution X10+C10
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The researchers Manel Pérez Pons y Carlos Rodriguez Muñoz at the IRBLleida laboratory (Photo courtesy of IRBLleida)

New Blood RNA Markers Help Advance Precision Medicine for Respiratory Patients

Risk stratification in hospitalized respiratory disease, particularly among older adults with COVID-19, remains challenging despite rich clinical datasets. Blood-based non-coding RNA biomarkers are promising,... Read more

Microbiology

view channel
Image: The “broth” used to monitor red blood cell depletion in whole blood spiked with one colony-forming-unit of E. coli bacteria, each incubated at different orbital shaking speeds—left to right: 0 RPM, 65 RPM, 120 RPM and 200 RPM—after four hours of incubation. This culturing raises a bacteria-rich, plasma-like layer of bacteria to the top of the vials, while clusters of stuck blood cells known as a Rouleaux formation sink to the bottom. (Image Credit: Pak Kin Wong)

New Diagnostic Workflow Identifies Bloodstream Pathogens and Antibiotic Response in Hours

Sepsis is a life-threatening complication of infection that affects more than 1.5 million patients annually in the United States and contributes to roughly one in three in-hospital deaths.... Read more

Pathology

view channel
Image: Researchers evaluated AI models that quantify tumor-infiltrating lymphocytes (TIL) on routine breast tissue slides, where higher TIL levels reflect stronger antitumor response and improved breast cancer outcomes (Image Credit: Shutterstock)

AI Matches Pathologists in Predicting Breast Cancer Prognosis from Immune Cells

Breast cancer is the most common cancer in Australian women, with more than 20,000 cases each year. Prognosis can be informed by counting tumor-infiltrating lymphocytes (TILs) on routine pathology slides,... Read more

Industry

view channel
Image: RaDaR ST uses a tumor-informed approach that identifies up to 48 patient-specific variants through whole-exome sequencing and tracks those variants in plasma to detect circulating tumor DNA (ctDNA) at very low variant allele fractions (VAFs) (Photo courtesy of Neogenomics)

Tumor-Informed MRD Assay Gains Medicare Coverage for Immunotherapy Monitoring

NeoGenomics’ RaDaR ST molecular residual disease (MRD) assay has received expanded coverage from the Centers for Medicare & Medicaid Services’ Molecular Diagnostic Services Program (MolDX) for monitoring... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.